- Home
- SRCE vs VERA Comparison
SRCE vs VERA Comparison
Compare SRCE & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRCE
- VERA
- Stock Information
- Founded
- SRCE 1863
- VERA 2016
- Country
- SRCE United States
- VERA United States
- Employees
- SRCE N/A
- VERA N/A
- Industry
- SRCE Major Banks
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- SRCE Finance
- VERA Health Care
- Exchange
- SRCE Nasdaq
- VERA Nasdaq
- Market Cap
- SRCE 1.5B
- VERA 1.7B
- IPO Year
- SRCE N/A
- VERA 2021
- Fundamental
- Price
- SRCE $60.65
- VERA $29.96
- Analyst Decision
- SRCE Hold
- VERA Buy
- Analyst Count
- SRCE 4
- VERA 9
- Target Price
- SRCE $71.25
- VERA $62.25
- AVG Volume (30 Days)
- SRCE 77.9K
- VERA 1.0M
- Earning Date
- SRCE 10-23-2025
- VERA 11-07-2025
- Dividend Yield
- SRCE 2.55%
- VERA N/A
- EPS Growth
- SRCE 14.53
- VERA N/A
- EPS
- SRCE 6.01
- VERA N/A
- Revenue
- SRCE $405,363,000.00
- VERA N/A
- Revenue This Year
- SRCE $17.85
- VERA N/A
- Revenue Next Year
- SRCE $1.85
- VERA N/A
- P/E Ratio
- SRCE $10.10
- VERA N/A
- Revenue Growth
- SRCE 9.59
- VERA N/A
- 52 Week Low
- SRCE $52.14
- VERA $18.53
- 52 Week High
- SRCE $68.13
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- SRCE 50.93
- VERA 56.32
- Support Level
- SRCE $58.79
- VERA $28.24
- Resistance Level
- SRCE $61.83
- VERA $30.98
- Average True Range (ATR)
- SRCE 1.50
- VERA 1.30
- MACD
- SRCE 0.22
- VERA -0.35
- Stochastic Oscillator
- SRCE 76.11
- VERA 43.77
About SRCE 1st Source Corporation
1st Source Corp, along with its subsidiary, offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans, which are given to privately owned business clients mainly located within the regional market areas, Consumer Services that consist of the full range of consumer banking products and services, Trust and Wealth Advisory Services, and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.